Get the Stockscreener App
5.11
4.66%
-0.25
After Hours:
5.11
Immucell Corp Stock (ICCC) Forecast
The Immucell Corp (ICCC) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.0267, representing a -21.20% decrease from the current price of $5.11. The highest analyst price target is $4.6767, and the lowest is $3.3767.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ICCC Price Target
Average 3.8281
(-25.09% Downside)
Is Immucell Corp (ICCC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.91 | Neutral |
| STOCH(9,6) | 55.37 | Neutral |
| STOCHRSI(14) | 11.05 | Buy |
| MACD(12,26) | 0.0878 | Sell |
| ADX(14) | 25.03 | Sell |
| William %R | -63.93 | Neutral |
| CCI(14) | -127.33 | Sell |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.2835
Sell
|
5.2547
Sell
|
| MA20 |
5.2818
Sell
|
5.2201
Sell
|
| MA50 |
4.925
Buy
|
4.9101
Buy
|
| MA100 |
4.2671
Buy
|
4.5851
Buy
|
| MA200 |
4.2851
Buy
|
4.4926
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, ICCC could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on ICCC, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 48.91 indicates that ICCC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.37 indicates that ICCC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.05 indicates that ICCC is oversold. This suggests that ICCC price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.03 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -127.33 indicates that ICCC is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ICCC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immucell Corp financial reports and earnings history, Immucell Corp (ICCC) stock could reach $4.301 by 2030, $1.8166 by 2040 and $3.3427 by 2050. See the projected annual prices until 2050 of the Immucell Corp stock below:
- Immucell Corp (ICCC) is expected to reach an average price of $2.5801 in 2035, with a high prediction of $3.3211 and a low estimate of $2.2101. This indicates an $-49.51% rise from the last recorded price of $5.11.
- Immucell Corp (ICCC) stock is projected to chart a bullish course in 2040, with an average price target of $1.4866, representing an $-70.91% surge from its current level. The forecast ranges from a conservative $1.3606 to a sky-high $1.8166.
- Our analysts predict Immucell Corp (ICCC) to jump -36.63% by 2045, soaring from $2.4984 to an average price of $3.2382, potentially reaching $3.67. While $2.4984 is the low estimate, the potential upside is significant.
- Immucell Corp (ICCC) stock is expected to climb by 2050, reaching an average of $2.8227, a $-44.76% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.3427 and $1.9776, respectively, highlighting the market's uncertainty.
Immucell Corp Stock (ICCC) Year by Year Forecast
Immucell Corp Stock (ICCC) Price Forecast for 2025
Immucell Corp Stock (ICCC) is expected to reach an average price of $4.5827 in 2025, with a high prediction of $6.7916 and a low estimate of $2.3738. This indicates an -10.32% fall from the last recorded price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $4.4166 | $3.3767 | $4.6767 | -13.57% |
| April, 2025 | $2.6165 | $2.4097 | $4.4177 | -48.80% |
| May, 2025 | $2.9158 | $2.3738 | $3.5448 | -42.94% |
| June, 2025 | $2.9099 | $2.482 | $3.4069 | -43.05% |
| July, 2025 | $3.135 | $2.4909 | $3.5598 | -38.65% |
| August, 2025 | $4.199 | $3.0614 | $4.439 | -17.83% |
| September, 2025 | $4.2161 | $3.6721 | $5.2501 | -17.49% |
| October, 2025 | $4.0145 | $3.7761 | $4.5367 | -21.44% |
| November, 2025 | $4.1122 | $3.7112 | $4.3522 | -19.53% |
| December, 2025 | $4.0173 | $3.9173 | $5.0953 | -21.38% |
Immucell Corp Stock (ICCC) Price Forecast for 2026
The predicted value for Immucell Corp (ICCC) in 2026 is set at an average of $7.9199. Estimates vary from a peak of $11.92 to a trough of $3.9183, indicating an +54.99% surge from the present price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.7113 | $3.9183 | $4.8114 | -7.80% |
| February, 2026 | $4.9454 | $4.4534 | $5.2824 | -3.22% |
| March, 2026 | $4.9795 | $4.3875 | $5.3485 | -2.55% |
| April, 2026 | $10.60 | $5.0255 | $11.92 | +107.53% |
| May, 2026 | $9.8886 | $7.4267 | $10.79 | +93.52% |
| June, 2026 | $8.4577 | $7.9907 | $10.23 | +65.51% |
| July, 2026 | $8.3879 | $7.2147 | $9.7968 | +64.15% |
| August, 2026 | $9.0568 | $7.8047 | $9.4035 | +77.24% |
| September, 2026 | $8.6619 | $7.7439 | $9.6929 | +69.51% |
| October, 2026 | $8.416 | $7.1779 | $9.03 | +64.70% |
| November, 2026 | $7.915 | $6.054 | $8.652 | +54.89% |
| December, 2026 | $8.12 | $6.916 | $9.0291 | +58.90% |
Immucell Corp Stock (ICCC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immucell Corp (ICCC) is $8.0117, with a high forecast of $9.7556 and a low forecast of $6.2677. This indicates an +56.78% increase from the last price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.6743 | $7.3206 | $8.6371 | +50.18% |
| February, 2027 | $7.6082 | $7.5162 | $8.3553 | +48.89% |
| March, 2027 | $7.3533 | $6.565 | $8.3202 | +43.90% |
| April, 2027 | $7.584 | $6.6853 | $8.0264 | +48.41% |
| May, 2027 | $6.8374 | $6.6514 | $7.7794 | +33.80% |
| June, 2027 | $7.1665 | $6.5345 | $7.3765 | +40.24% |
| July, 2027 | $8.4406 | $6.8275 | $9.2615 | +65.18% |
| August, 2027 | $7.0946 | $6.9058 | $8.8416 | +38.84% |
| September, 2027 | $7.1397 | $6.2677 | $9.7556 | +39.72% |
| October, 2027 | $6.8038 | $6.4338 | $7.5391 | +33.15% |
| November, 2027 | $7.3278 | $6.7548 | $7.6677 | +43.40% |
| December, 2027 | $6.9629 | $6.7129 | $8.4179 | +36.26% |
Immucell Corp Stock (ICCC) Price Forecast for 2028
In 2028, Immucell Corp (ICCC) is projected to reach an average price of $5.2729, with a high projection of $7.4281 and a low estimate of $3.1176. This indicates an +3.19% rise from the last price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.857 | $5.857 | $7.0549 | +14.62% |
| February, 2028 | $6.301 | $5.778 | $7.21 | +23.31% |
| March, 2028 | $6.8361 | $6.0322 | $7.072 | +33.78% |
| April, 2028 | $5.3202 | $4.8102 | $7.4281 | +4.11% |
| May, 2028 | $5.0652 | $4.9225 | $6.2107 | -0.88% |
| June, 2028 | $6.2893 | $4.8364 | $6.6783 | +23.08% |
| July, 2028 | $5.9434 | $5.9434 | $6.4923 | +16.31% |
| August, 2028 | $4.3384 | $4.1134 | $6.2344 | -15.10% |
| September, 2028 | $3.8225 | $3.5295 | $4.4295 | -25.20% |
| October, 2028 | $3.7566 | $3.6535 | $4.1055 | -26.49% |
| November, 2028 | $4.0615 | $3.1176 | $4.2096 | -20.52% |
| December, 2028 | $3.8657 | $3.7757 | $4.9137 | -24.35% |
Immucell Corp Stock (ICCC) Price Forecast for 2029
The 2029 price forecast for Immucell Corp Stock (ICCC) is $3.8941 on average, with a high prediction of $4.7382 and a low estimate of $3.05. This represents an -23.79% decrease from the previous price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.3008 | $3.8177 | $4.7382 | -15.84% |
| February, 2029 | $3.5648 | $3.3948 | $4.4818 | -30.24% |
| March, 2029 | $4.2389 | $3.2859 | $4.2389 | -17.05% |
| April, 2029 | $3.903 | $3.703 | $4.5209 | -23.62% |
| May, 2029 | $4.288 | $3.2657 | $4.433 | -16.09% |
| June, 2029 | $3.3721 | $3.3201 | $4.2891 | -34.01% |
| July, 2029 | $3.9862 | $3.2341 | $3.9962 | -21.99% |
| August, 2029 | $4.2112 | $3.6072 | $4.4892 | -17.59% |
| September, 2029 | $4.0453 | $3.7333 | $4.2975 | -20.84% |
| October, 2029 | $4.1404 | $3.8494 | $4.3783 | -18.98% |
| November, 2029 | $3.9344 | $3.9034 | $4.3514 | -23.01% |
| December, 2029 | $3.62 | $3.05 | $4.1165 | -29.16% |
Immucell Corp Stock (ICCC) Price Forecast for 2030
Immucell Corp Stock (ICCC) is expected to reach an average price of $3.2664 in 2030, with a high forecast of $5.4533 and a low forecast of $1.0795. This signifies an -36.08% decrease from the last price of $5.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.8252 | $3.1841 | $4.301 | -25.14% |
| February, 2030 | $3.4573 | $3.3483 | $4.1474 | -32.34% |
| March, 2030 | $3.2844 | $3.2664 | $3.7003 | -35.73% |
| April, 2030 | $2.8652 | $2.6745 | $3.3584 | -43.93% |
| May, 2030 | $2.8547 | $2.4286 | $3.1786 | -44.14% |
| June, 2030 | $2.4928 | $1.9887 | $2.9808 | -51.22% |
| July, 2030 | $2.2029 | $2.1009 | $2.7972 | -56.89% |
| August, 2030 | $2.4611 | $2.1897 | $2.8611 | -51.84% |
| September, 2030 | $2.4892 | $2.1131 | $2.6386 | -51.29% |
| October, 2030 | $2.4093 | $2.1753 | $5.4533 | -52.85% |
| November, 2030 | $1.3275 | $1.2175 | $3.3434 | -74.02% |
| December, 2030 | $1.2962 | $1.0795 | $2.5397 | -74.63% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):